Compositions including triciribine and epidermal growth factor receptor inhibitor compounds or salts thereof and methods of use thereof
作者： Said M. Sebti , Jin Q. Cheng
DOI:
关键词:
摘要: This application relates to combination therapies including triciribine compounds and epidermal growth factor receptor inhibitor compounds, particularly erlotinib-like compositions with reduced toxicity for the treatment prevention of tumors, cancer, other disorders associated abnormal cell proliferation.
lens.org 参考文章(375)
Werner Krause, Peter Muschick, Use of neoangiogenesis markers for diagnosing and treating tumours by therapy ,(1999)
Robert A. Bok, Eric J. Small, The treatment of advanced prostate cancer with ketoconazole: safety issues. Drug Safety. ,vol. 20, pp. 451- 458 ,(1999) , 10.2165/00002018-199920050-00005
Zanke B, Suzuki H, Squire J, Mak Tw, Henry M, Griesser H, Patterson B, Minden M, A hematopoietic protein tyrosine phosphatase (HePTP) gene that is amplified and overexpressed in myeloid malignancies maps to chromosome 1q32.1. Leukemia. ,vol. 8, pp. 236- 244 ,(1994)
Frederick R. Appelbaum, Janet W. Andersen, James H. Feusner, Angela Ogden, Jacob M. Rowe, Richard S. Larson, Christopher François, Lois Shepherd, Charles A. Schiffer, Martin S. Tallman, Peter H. Wiernik, Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood. ,vol. 95, pp. 90- 95 ,(2000) , 10.1182/BLOOD.V95.1.90
Ida Nilsson, Ingrid Hoffmann, Cell cycle regulation by the Cdc25 phosphatase family Progress in Cell Cycle Research. ,vol. 4, pp. 107- 114 ,(2000) , 10.1007/978-1-4615-4253-7_10
Jonathan M Ellery, Sarah J Kempshall, Peter J Nicholls, Activation of the interleukin 2 receptor Cellular Signalling. ,vol. 12, pp. 367- 373 ,(2000) , 10.1016/S0898-6568(00)00085-1
Karl Rickels, Edward Schweizer, The clinical presentation of generalized anxiety in primary-care settings: practical concepts of classification and management. The Journal of Clinical Psychiatry. ,vol. 58, pp. 4- 10 ,(1997)
Jens W. Eckstein, Cdc25 as a potential target of anticancer agents. Investigational New Drugs. ,vol. 18, pp. 149- 156 ,(2000) , 10.1023/A:1006377913494
S Marsoni, C K Grieshaber, Relation of preclinical toxicology to findings in early clinical trials. Cancer treatment reports. ,vol. 70, pp. 65- 72 ,(1986)
M. J. O'Connell, R. L. Richardson, L. K. Kvols, D. M. Kroschel, P. J. Basseches, G. Powis, Disposition of tricyclic nucleoside-5'-monophosphate in blood and plasma of patients during phase I and II clinical trials. Cancer treatment reports. ,vol. 70, pp. 359- 362 ,(1986)